Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia

被引:34
|
作者
Braamskamp, Marjet J. A. M. [1 ,2 ]
Kastelein, John J. P.
Kusters, D. Meeike
Hutten, Barbara A.
Wiegman, Albert
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9,Room F4-136, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Meibergdreef 9,Room F4-136, NL-1105 AZ Amsterdam, Netherlands
关键词
CHILDREN; EFFICACY; THERAPY; SAFETY;
D O I
10.1016/j.jacc.2015.11.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:455 / 456
页数:2
相关论文
共 50 条
  • [41] Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia
    Agarwala, Anandita
    Bekele, Nathan
    Deych, Elena
    Rich, Michael W.
    Hussain, Aliza
    Jones, Laney K.
    Sturm, Amy C.
    Aspry, Karen
    Nowak, Elizabeth
    Ahmad, Zahid
    Ballantyne, Christie M.
    Goldberg, Anne C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (17):
  • [42] COLESEVELAM ADDED TO STABLE COMBINATION OF STATIN AND EZETIMIBE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; THE TRIPLE TRIAL
    Trip, M.
    Huijgen, R.
    Bruckert, E.
    Abbink, E.
    Stalenhoef, A.
    Imholz, B.
    Durrington, P.
    Eriksson, M.
    Visseren, F.
    Schaefer, J.
    Kastelein, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [43] Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood
    Braamskamp, Marjet J. A. M.
    Kusters, D. Meeike
    Wiegman, Albert
    Avis, Hans J.
    Wijburg, Frits A.
    Kastelein, John J. P.
    van Trotsenburg, A. S. Paul
    Hutten, Barbara A.
    ATHEROSCLEROSIS, 2015, 241 (02) : 427 - 432
  • [44] Impact of Statin Treatment on the Clinical Fate of Heterozygous Familial Hypercholesterolemia
    Harada-Shiba, Mariko
    Sugisawa, Takako
    Makino, Hisashi
    Abe, Mitsuru
    Tsushima, Motoo
    Yoshimasa, Yasunao
    Yamashita, Takahiro
    Miyamoto, Yoshihiro
    Yamamoto, Akira
    Tomoike, Hitonobu
    Yokoyama, Shinji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (07) : 667 - 674
  • [45] Statin therapy in children with familial hypercholesterolemia: a meta-analysis
    Lewek, J.
    Surma, S.
    Bytyci, I.
    Banach, M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2678 - 2678
  • [46] Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
    Mundal, Liv J.
    Igland, Jannicke
    Svendsen, Karianne
    Holven, Kirsten B.
    Leren, Trond P.
    Retterstol, Kjetil
    JAMA NETWORK OPEN, 2022, 5 (04) : E227715
  • [47] CARDIOVASCULAR DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS ON STATIN TREATMENT
    Marco-Benedi, V.
    Perez-Calahorra, S.
    Plana, N.
    Pedro-Botet, J. C.
    Ascaso, J.
    Lahoz, C.
    Almagro, F.
    Ros, E.
    Brea, A.
    Suarez-Tembra, M.
    Sanchez-Hernandez, R. M.
    Vila Belmonte, A.
    Civeira, F.
    ATHEROSCLEROSIS, 2016, 252 : E44 - E44
  • [48] Safety of statin treatment in children with familial hypercholesterolemia: Filling the gaps
    Rocha, Viviane Z.
    Santos, Raul D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (01) : 12 - 15
  • [49] NON-ADHERENCE TO STATIN TREATMENT IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Hof, Michel H.
    Besseling, Joost
    Hovingh, G. K.
    Kastelein, John J.
    Hutten, Barbara A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 75 - 75
  • [50] Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia
    van Tits, LJH
    van Himbergen, TM
    Lemmers, HLM
    de Graaf, J
    Stalenhoef, AFH
    ATHEROSCLEROSIS, 2006, 185 (02) : 307 - 312